Another important key mechanism in renal I/R injury is represented by complement system activation
We have advanced DMARDs (Disease Modifying Anti-Rheumatic Drugs), targeted synthetic DMARDs, biologic therapies, image-guided joint interventions, comprehensive rehabilitation, orthotics, and precision medicine
Generally, GLP-1 agonist medications are FDA approved for adults aged 18 years and older with certain body mass indexes (BMI) (typically a BMI of 30 or above, or a BMI of 27 or above if you have a weight-related health condition such as hypertension, high cholesterol, weight-related anxiety, liver disease, sleep apnea or PCOS)
O., Bord, S., Horner, A., Chatterjee, V
Over time, it can lead to additional health problems and complications